Itron (ITRI) Beats Stock Market Upswing: What Investors Need to Know

Itron (ITRI) recently outperformed the S&P 500 with a 1.19% daily gain and a 7.58% monthly increase. While analysts anticipate a year-over-year decline of 19.57% in EPS and 6.34% in revenue for its upcoming October 2025 earnings, full fiscal year estimates project an 8.01% EPS growth and a 2.76% revenue decrease. The stock maintains a Zacks Rank #1 (Strong Buy) and exhibits attractive valuation metrics, trading at a Forward P/E of 21.81 and a PEG ratio of 0.73, both significantly below industry averages, suggesting potential for continued outperformance despite near-term revenue headwinds.

Analysis

Itron (ITRI) has demonstrated notable market outperformance, with its stock price increasing by 1.19% on the recent trading day and 7.58% over the past month, significantly exceeding the S&P 500 and the Computer and Technology sector. Despite this strong momentum, the company faces near-term headwinds, with analysts projecting a 19.57% year-over-year decline in EPS to $1.48 and a 6.34% revenue reduction to $576.45 million for the upcoming October 2025 earnings report.

However, the full fiscal year outlook remains more optimistic, with Zacks Consensus Estimates forecasting an 8.01% increase in EPS to $6.07, alongside a modest 2.76% revenue decline to $2.37 billion. Itron currently holds a Zacks Rank #1 (Strong Buy), a quantitative rating system indicating strong potential for outperformance, although the Zacks Consensus EPS estimate has remained unchanged over the last 30 days.

From a valuation perspective, Itron appears attractive, trading at a Forward P/E of 21.81, which is a discount compared to its industry average of 23.79. Its PEG ratio of 0.73 is also substantially lower than the Electronics - Testing Equipment industry average of 2.65, suggesting a favorable growth-adjusted valuation within a highly-ranked industry (Zacks Industry Rank 13, top 6%).

Key Decisions for Investors

• Consider Itron (ITRI) for potential long positions, supported by its Zacks Rank #1 and attractive valuation metrics relative to its industry.
• Monitor the upcoming October 2025 earnings report closely for actual performance against the projected near-term declines in EPS and revenue, as this could influence short-term price action.
• Evaluate the company's full fiscal year guidance and any subsequent changes in analyst estimates, given the positive long-term EPS growth forecast despite anticipated quarterly revenue contraction.